Next 10 |
2023-06-01 17:02:47 ET Adaptimmune ( NASDAQ: ADAP ) said that it has completed its planned merger with fellow T-cell therapy developer TCR2 ( TCRR ). The immunology companies announced the merger in March. After the closing Adaptimmune shareholders own around 75% of the comb...
2023-05-11 07:52:15 ET TCR2 Therapeutics press release ( NASDAQ: TCRR ): Q1 GAAP EPS of -$1.03 misses by $0.34 . TCR 2 ended the first quarter of 2023 with $110.3 million in cash, cash equivalents, and investments compared to $149.2 million as of December 31, 2022....
CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (Nasdaq: TCRR) (TCR 2 or the Company), a clinical-stage cell therapy company with a pipeline of novel next-generation T cell therapies for patients suffering from solid tumors, today announced financial results for...
2023-05-08 08:22:53 ET EZFill Holdings ( EZFL ) +65% . Immuron Limited ( IMRN ) +74% surges ~65% as FDA lifts hold to start trial of bacterial diarrhea drug. PacWest Bancorp ( PACW ) +39% leads regional bank stocks higher after dividend cut, bank deposit ...
2023-04-21 14:24:33 ET Summary ADAP is swapping 1.5117 of its shares for every TCRR share. There is a huge spread between the two values, so existing shareholders can lock in a big gain once the deal closes. The spread is available as an arbitrage (by shorting ADAP) with a few...
2023-04-03 16:41:21 ET Summary Merger arbitrage spreads are wide. There are plenty of opportunities with spreads of up to 118%. This is a review of the most interesting transactions in the merger arbitrage space. Merger arbitrage is an event-driven investment strategy of...
NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Radius Global Infrastructure, Inc....
NEW YORK, NY / ACCESSWIRE / March 30, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: U.S. Xpress Enterprises, Inc. (NYSE:...
2023-03-26 07:12:58 ET Summary ADAP is down after merging with TCRR, while TCRR is up. The merger dilutes ADAP, but in return, it gets one year of additional cash and the TCRR pipeline for free. The merger looks like a smart deal for ADAP. For further det...
2023-03-23 07:59:00 ET TCR2 Therapeutics press release ( NASDAQ: TCRR ): Q4 GAAP EPS of -$1.56 misses by $0.74 . TCR² ended the fourth quarter of 2022 with $149.2 million in cash, cash equivalents, and investments compared to $265.6 million as of December 31,...
News, Short Squeeze, Breakout and More Instantly...
TCR2 Therapeutics Inc. Company Name:
TCRR Stock Symbol:
NASDAQ Market:
TCR2 Therapeutics Inc. Website:
CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (Nasdaq: TCRR) (TCR 2 or the Company), a clinical-stage cell therapy company with a pipeline of novel next-generation T cell therapies for patients suffering from solid tumors, today announced financial results for...
NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Radius Global Infrastructure, Inc....
NEW YORK, NY / ACCESSWIRE / March 30, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: U.S. Xpress Enterprises, Inc. (NYSE:...